-

Eurofins Launches BQ.1 and BQ.1.1 Droplet Digital PCR Assay (ddPCR) for SARS-CoV-2 Wastewater Testing

Highly sensitive ddPCR analytical tool will help identify rapidly increasing SARS-CoV-2 Variants of Concern BQ.1 and BQ.1.1 in wastewater samples domestically and internationally, expanding the comprehensive SARS-CoV-2 wastewater monitoring platform of the Eurofins network.

WEST SACRAMENTO, Calif.--(BUSINESS WIRE)--Eurofins Environment Testing Northern California: Wastewater (EWW) and Eurofins Pandemic Prevention Services (EPPS) today launched a droplet digital PCR (ddPCR) assay for the combined quantitative analysis of SARS-CoV-2 Variants of Concern (VoC) BQ.1 and BQ.1.1 in wastewater. This expansion of EWW and EPPS’ comprehensive SARS-CoV-2 wastewater monitoring platform follows a strategic initiative to continuously monitor novel VoC showing significant incidence within the United States. Omicron subvariants BQ.1 and BQ.1.1 currently comprise >35% of the SARS-CoV-2 virus variant distribution in the US and are increasing at rates that supersede all other current SARS-CoV-2 variants. The World Health Organization has stated that while there is currently no data on severity or immune escape in human studies, BQ.1 shows a significant growth advantage over other circulating Omicron variants and thus warrants monitoring.

Empowering community leaders and stakeholders to make evidence-based decisions is central to the Eurofins network’s wastewater surveillance offering - accomplished through robust scientific techniques, complete project development/support, and access to teams of established industry experts in wastewater epidemiology.

Optimized management of personnel and resources is essential to mitigating the effects of public health issues and protecting community welfare. Governments, public institutions, and businesses have leveraged wastewater monitoring to protect the populations they serve, and Eurofins companies continue to offer technical expertise and support to ensure their strategies and mitigation efforts remain effective.

Key Features

  • Adaptable and scalable wastewater monitoring platform for total SARS-CoV-2 and currently circulating VoC.
  • Complete project development services and ongoing professional support from the global Eurofins network of established wastewater monitoring professionals.
  • ddPCR platform provides analytical sensitivity unobtainable through other biological monitoring methods.
  • 72-hour data turnaround time provides a near real-time source of community health information.

EPPS’ ddPCR wastewater monitoring platform and project design services are available immediately.

ENDS

About Eurofins– the global leader in bio-analysis
Eurofins is Testing for Life. With 61,000 staff across a network of 940 laboratories in 59 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.
Eurofins Shares are listed on Euronext Paris Stock Exchange.

Contacts

For further information:
Brooke Maharg
Brooke.Maharg@ET.EurofinsUS.com

Eurofins

BOURSE:ERF

Release Versions

Contacts

For further information:
Brooke Maharg
Brooke.Maharg@ET.EurofinsUS.com

More News From Eurofins

The Eurofins Consumer Product Testing Network Completes Significant Laboratory Expansion in Vietnam

HO CHI MINH CITY, Vietnam--(BUSINESS WIRE)--Eurofins Consumer Product Testing Vietnam has completed a major expansion, seeing the laboratory move to a purpose-built 7,000 sq. m laboratory in Ho Chi Minh City. This new facility provides more than two and a half times the floor space of Eurofins Consumer Product Testing Vietnam’s previous site. This investment strengthens the Eurofins Consumer Product Testing network’s capability to deliver world-class testing solutions and supports Vietnam’s rap...

Eurofins: Weekly Report on Share Repurchases From 01st December to 05th December 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 12/01/2025 FR0014000MR3 20 000 58.9527 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 12/02/2025 FR0014000MR3 20 000 59.3808 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 12/0...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 November 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedi (including the issuer ID allocated by the CSSF EUROFINS SCIENTIFIC SE – E1013 Identity of t...
Back to Newsroom